Brewin Dolphin Wealth Management LTD Abiomed Inc Transaction History
Brewin Dolphin Wealth Management LTD
- $917 Million
- Q2 2022
A detailed history of Brewin Dolphin Wealth Management LTD transactions in Abiomed Inc stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 75 shares of ABMD stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75
Previous 75
-0.0%
Holding current value
$0
Previous $25,000
24.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ABMD
# of Institutions
12Shares Held
137KCall Options Held
0Put Options Held
0-
Eaton Vance Management Boston, MA127KShares$00.05% of portfolio
-
Corient Capital Partners, LLC Newport Beach, CA5.3KShares$00.1% of portfolio
-
Advisor Partners LLC Walnut Creek, CA1.31KShares$00.02% of portfolio
-
Redpoint Investment Management Pty LTD1.11KShares$00.04% of portfolio
-
Bluestein R H & CO LLC Birmingham, MI1.03KShares$00.02% of portfolio
About ABIOMED INC
- Ticker ABMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 45,460,900
- Description
- Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...